Table 1. Patients' characteristics (n=65).
| Characteristics | Values | |
|---|---|---|
| Age (yr) | 38.8±7.3 (18–58) | |
| BMI (kg/m2) | 26.3±7.0 (16.3–49.1) | |
| Parity | ||
| 0 | 41 (63.1) | |
| 1 | 11 (16.9) | |
| 2 | 11 (16.9) | |
| 3 | 2 (3.1) | |
| Histologic type | ||
| SH without atypia | 27 (41.5) | |
| CH without atypia | 28 (43.1) | |
| SH with atypia | 1 (1.5) | |
| CH with atypia | 9 (13.9) | |
| Treatment | ||
| MPA 10 mg/day, cyclic | 19 (29.2) | |
| MPA 10 mg/day, continuous | 22 (33.9) | |
| LNG-IUS | 24 (36.9) | |
Data are expressed as the means ± standard deviation (range) or number (%).
BMI, body mass index; CH, complex hyperplasia; LNG-IUS, levonorgestrel-releasing intrauterine system; MPA, medroxyprogesterone acetate; SH, simple hyperplasia.